Lazard Asset Management
ARA

Lazard Asset Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Lazard Asset Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,399
Closed -$8K – 1718
2019
Q3 		$8K Buy
+1,399
New +$10.4K ﹤0.01% 1332

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lazard Asset Management's ARA Position: Q4 2019 in Review

Lazard Asset Management sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2019, closing a stake of 1,399 shares — an estimated $8K sold.

Lazard Asset Management first reported a position in ARA in Q3 2019 and held it in 1 quarter. The position peaked at $8K in Q3 2019. 66 funds tracked by Wall St. Rank hold ARA as of Q4 2019.

  • Lazard Asset Management reported no remaining American Renal Associates Holdings, Inc position as of Q4 2019 after selling out during the quarter.
  • Lazard Asset Management sold 1,399 American Renal Associates Holdings, Inc shares in Q4 2019, an estimated $8K.
  • Lazard Asset Management first reported a position in American Renal Associates Holdings, Inc in Q3 2019 and held it in 1 quarter.
  • Lazard Asset Management's American Renal Associates Holdings, Inc position peaked at $8K in Q3 2019.
  • 66 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2019.

Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.